Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Brazil’s integrated electric utility, Companhia Energetica de Minas Gerais ( CIG - Analyst Report ) , also known as CEMIG is all set to increase its stake in Brazil’s energy consortium, Capim Branco Energia Consortium.
The deal signed between Cemig’s wholly-owned subsidiary, Cemig Capim Branco Energia S.A. and Suzano Papel e Celulose S.A. and subsidiaries, one of the largest paper and pulp companies in Brazil, requires Cemig Capim to purchase its share of Suzano’s 17.9% stake in Capim Branco Energia Consortium.
Suzano’s stake in the consortium represents 81MW of installed capacity, at the Amador Aguiar I and II hydroelectric plants. The 17.9% stake sale is valued at approximately R$320 million while Cemig’s share is of about R$82 million.
The stake purchase will increase Cemig’s interest in Capim Branco from its existing 21.1% stake. Cemig now intends to add to its existing stake further in the consortium through purchase of leftover stake, only if other members don’t opt for the same. Other partners in the energy consortium are Vale SA ( VALE - Analyst Report ) with a 48.4% stake and Votorantim with a 12.6% stake.
Ranking fifth among the electricity generators in Brazil, Cemig derives approximately 97% of electricity from hydroelectric sources. The company, with its integrated nature of activity (generating and distributing energy) and aggressive expansion plan is making its presence felt among the industrial customers both in the south and southeast of Brazil.
The current Zacks Consensus earnings estimate for years 2012 and 2013 are $2.55 and $1.52 per ADR. These represent year-over-year growth of 34.2% for 2012 and decline of 40.2% for 2013.
Cemig currently bears a Zacks #3 Rank, translating into a short-term Hold rating. On the other hand, the company’s prime competitor Companhia Paranaense de Energia ( ELP - Analyst Report ) also bears a Zacks #3 (Hold) Rank.
Read the full Analyst Report on VALE
Read the full Analyst Report on ELP
Read the full Analyst Report on CIG